Ikena Oncology earnings were -$41.7M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest IKNA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$8.6M, down 5.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IKNA reported annual earnings of -$49.2M, with -27.8% growth.
On IKNA's earnings call on Invalid Date, Ikena Oncology (NASDAQ: IKNA) reported Q1 2025 earnings per share (EPS) of -$0.18, up 45.45% year over year. Total IKNA earnings for the quarter were -$8.62 million. In the same quarter last year, Ikena Oncology's earnings per share (EPS) was -$0.33.
As of the last Ikena Oncology earnings report, Ikena Oncology is currently losing money. Ikena Oncology's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$41.71 million, a 40.5% decrease year over year.
What was IKNA's earnings growth in the past year?
As of Ikena Oncology's earnings date in Invalid Date, Ikena Oncology's earnings has grown year over year. IKNA earnings in the past year totalled -$41.71 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.